Advanced Prostate Cancer Consensus Conference (APCCC)

9 October 2021
Watch the recordings
APCCC online
Live moderation by panelists, live voting & “Aperitivo”-Challenge the Experts Sessions
27 April 2022
Translational Prostate Cancer Symposium
28 - 30 April 2022
Lugano / Switzerland
Hybrid Conference

APCCC 2022 - Draft Programme APCCC 2019 - report

NOTICE ON APCCC 2021 / 2022

The APC Executive Committee is highly conscientious of the impact that the current COVID-19 pandemic has on travel and event restrictions. We strongly believe in mitigating the spread of the virus while still maintaining the ability to facilitate the exchange between experts, and positively impact the lives of patients with advanced prostate cancer.

Therefore the APCCC 2022 is planned as a hybrid event. We will hold the conference as a face-to-face meeting, while providing the benefits of the conference in an online format. This opens opportunities for attendance to valuable experts from around the world, who may otherwise not be able to attend. Additionally, it provides us the flexibility to move to a completely virtual format, should a face-to-face meeting not be feasible next year.

In addition to the main meeting, there will be a virtual consensus meeting in October 2021 with a live moderation by panelists and a live voting.

Stay Connected

Find below our Twitter-Feed to get the hottest news.

RT @urotoday: @NCCN guidelines on #ProstateCancer: a focus on castration-resistant prostate cancer. @WallisCJD @UofT and @zklaassen_md @GAC…

APCCC_Lugano 28 October

RT @CurrentOncology: 🗣️New Brief Report just published: Single-Center Comparison of [64Cu]-DOTAGA-PSMA and [18F]-PSMA PET–CT for Imaging #P…

APCCC_Lugano 27 October

RT @Radiology_AI: Datasets of advanced prostate cancer, myeloma, and advanced breast cancer were used to develop a denoising model for whol…

APCCC_Lugano 27 October

RT @Ecastromarcos: Consenso entre los expertos en cáncer de prostata de #APCCC21: los clinicos deberían poder solicitar el estudio genético…

APCCC_Lugano 27 October

RT @UroOncologyOk: Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer - MDPI

APCCC_Lugano 27 October

RT @Jorge_GarciaRod: APCCC 2021: Panel Results from the Metastatic Hormone Sensitive Prostate Cancer Session

APCCC_Lugano 26 October